Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Prolactin may be important for skin growth and immune function.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Moderately high prolactin levels do not cause hair loss in women.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Acne in dark skin is influenced by environmental factors and can lead to hyperpigmentation, with various treatment options available.